恒鋒工具(300488.SZ):研製的冷擠壓成型刀具目前廣泛用於軋製絲槓加工
格隆匯2月21日丨恒鋒工具(300488.SZ)在特定對象調研表示,公司在減速器領域客户較多,公司齒輪刀具、拉削刀具廣泛應用於減速器齒輪類零件加工,如尼得科傳動技術(浙江)有限公司、寧波中大力德智能傳動股份有限公司、友川精密技術(東莞)有限公司、台邦電機工業集團有限公司、浙江環動機器人關節科技股份有限公司等都是公司客户,另外一些減速器相關齒輪零部件生產廠家很多也是公司客户。公司研製的冷擠壓成型刀具目前廣泛用於軋製絲槓加工,如汽車電動座椅、電動天窗等中的絲槓加工。據公司瞭解,目前國內人形機器人滾柱絲桿加工處於起步階段,公司將持續關注此類產品的加工工藝。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.